NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 176 filers reported holding NEVRO CORP in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $10,018,800 | -15.0% | 253,000 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $11,790,000 | +6.3% | 253,000 | 0.0% | 0.00% | +50.0% |
Q2 2022 | $11,089,000 | -39.4% | 253,000 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $18,299,000 | -10.8% | 253,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $20,511,000 | -30.3% | 253,000 | 0.0% | 0.00% | -40.0% |
Q3 2021 | $29,444,000 | -29.8% | 253,000 | 0.0% | 0.01% | -28.6% |
Q2 2021 | $41,945,000 | +18.8% | 253,000 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $35,294,000 | +27.4% | 253,000 | +58.1% | 0.01% | +40.0% |
Q4 2020 | $27,696,000 | +24.3% | 160,000 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $22,288,000 | +16.6% | 160,000 | 0.0% | 0.01% | 0.0% |
Q2 2020 | $19,115,000 | +19.5% | 160,000 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $15,997,000 | -14.9% | 160,000 | 0.0% | 0.01% | +25.0% |
Q4 2019 | $18,806,000 | +36.7% | 160,000 | 0.0% | 0.00% | +33.3% |
Q3 2019 | $13,755,000 | +32.6% | 160,000 | 0.0% | 0.00% | +50.0% |
Q2 2019 | $10,373,000 | +3.7% | 160,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $10,002,000 | +60.8% | 160,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $6,222,000 | -31.8% | 160,000 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $9,120,000 | -28.6% | 160,000 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $12,776,000 | -7.9% | 160,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $13,867,000 | +25.5% | 160,000 | 0.0% | 0.00% | +50.0% |
Q4 2017 | $11,046,000 | -24.0% | 160,000 | 0.0% | 0.00% | -33.3% |
Q3 2017 | $14,541,000 | +22.1% | 160,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $11,909,000 | -20.6% | 160,000 | 0.0% | 0.00% | -25.0% |
Q1 2017 | $14,992,000 | +55.1% | 160,000 | -36.0% | 0.00% | +33.3% |
Q4 2014 | $9,668,000 | – | 250,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |